ELV - Elevance Health Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$444.06
DETAILS
HIGH:
$498.00
LOW:
$391.00
MEDIAN:
$456.00
CONSENSUS:
$444.06
UPSIDE:
10.15%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-17 | BOUDREAUX GAIL | director, officer: President and CEO | BUY | 2,045 | $368.25 | $753K |
| 2026-07-17 | PERU RAMIRO G | director | BUY | 1,000 | $366.05 | $366K |
| 2026-07-17 | BOUDREAUX GAIL | director, officer: President and CEO | BUY | 680 | $366.41 | $249K |
| 2026-06-12 | Penczek Ronald W | officer: CAO & Controller | SELL | 369 | $403.16 | $149K |
| 2026-06-11 | Dixon Robert L JR | director | SELL | 151 | $401.77 | $61K |
| 2026-05-19 | Penczek Ronald W | officer: CAO & Controller | M-Exempt | 654 | $271.27 | $177K |
| 2026-05-19 | Penczek Ronald W | officer: CAO & Controller | SELL | 1,531 | $403.13 | $617K |
| 2026-05-19 | Penczek Ronald W | officer: CAO & Controller | M-Exempt | 877 | $311.48 | $273K |
| 2026-05-13 | DeVore Susan D. | director | A-Award | 563 | -- | -- |
| 2026-05-13 | SCHULMAN AMY W | director | A-Award | 563 | -- | -- |
| 2026-05-13 | PERU RAMIRO G | director | A-Award | 563 | -- | -- |
| 2026-05-13 | COLLIS STEVEN H | director | A-Award | 563 | -- | -- |
| 2026-05-13 | Jallal Bahija | director | A-Award | 563 | -- | -- |
| 2026-05-13 | Schneider Ryan M. | director | A-Award | 563 | -- | -- |
| 2026-05-13 | Dixon Robert L JR | director | A-Award | 563 | -- | -- |
| 2026-05-13 | STRABLE-SOETHOUT DEANNA D | director | A-Award | 563 | -- | -- |
| 2026-05-13 | HAY LEWIS III | director | A-Award | 563 | -- | -- |
| 2026-05-13 | Neri Antonio F | director | A-Award | 563 | -- | -- |
| 2026-03-12 | SCHULMAN AMY W | director | SELL | 26 | $287.50 | $7K |
| 2026-03-06 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | SELL | 3,196 | $284.92 | $911K |
| 2026-03-05 | COLLIS STEVEN H | director | BUY | 3,000 | $289.84 | $870K |
| 2026-03-02 | BOUDREAUX GAIL | director, officer: President and CEO | F-InKind | 6,713 | $294.07 | $2.0M |
| 2026-03-02 | Haytaian Peter D | officer: EVP & Pres Carelon & CarelonRx | F-InKind | 1,201 | $294.07 | $353K |
| 2026-03-03 | Kaye Mark | officer: EVP & CFO | F-InKind | 353 | $284.03 | $100K |
| 2026-03-02 | Norwood Felicia F | officer: EVP &Chief Health Benefits Ofr | A-Award | 23,512 | $294.07 | $6.9M |